510(k) Report

510(k) · Cleared

Cleared

BD Directigen EZ RSV

K101514510(k) TraditionalCleared Jul 9, 201037-day reviewClass I21 CFR 866.3480

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Becton, Dickinson & CO · GQG Antigen, Cf (Including Cf Controls), Respiratory Syncytial Virus

Cleared on Jul 9, 2010 as substantially equivalent to K022133 (Becton, Dickinson & CO, 2002) after a 37-day review. Its family tree reaches back 2 generations to 1988.

Decided
Jul 9, 2010
Review
37 days
Class
Class I
Product code
GQG
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K882629 (1988). No later device cites it as a predicate yet.

  1. Root · 2 generations backK882629 Directigen Respiratory Syncytial Virus Test KitBd Becton Dickinson Vacutainer Systems Preanalytic · 1988
  2. 1 generation backK022133 BD Directigen EZ RSV KitBecton, Dickinson & CO · 2002 · Recalled
  3. This deviceK101514 BD Directigen EZ RSVBecton, Dickinson & CO · 2010
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K882629Directigen Respiratory Syncytial Virus Test KitBd Becton Dickinson Vacutainer Systems Preanalytic1988—
−1K022133BD Directigen EZ RSV KitBecton, Dickinson & CO20021
0 (this device)K101514BD Directigen EZ RSVBecton, Dickinson & CO2010—
FIG. 1 — Lineage of K101514, 1988–2010Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GQG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GQG device

  1. #1 K253318 Clungene RSV Antigen Rapid Testscore 10.8 · 1 generation · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K022133BD Directigen EZ RSV Kit
Summary page 1
…gical reagents DEVICE CLASSIFICATION: 21 CFR 866.3480 PREDICATE DEVICES: BID Directigen Tm EZ RSV assay (K022133) INTENDED USE: The DirectigenTm EZ RSV test is a rapid chromatographic immunoassay for the direct and qualitative detection of…
Becton, Dickinson & CO20021

Also cleared against K022133: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 22 years and passes through 2 companies; a new generation was cleared every 14.1 years on median.
  • 1 of the 2 ancestors has a recall of any class.
  • 2 other devices also cite its predicate K022133.

How does its category compare?

All GQG devices

GQG Antigen, Cf (Including Cf Controls), Respiratory Syncytial Virus: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · GQG

1in 2024

2007: 12009: 12010: 22012: 12013: 32017: 12024: 12026 (partial year): 1
2007high 3 (2013) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GQG

93in 2013

2013: 93 days median
2007high 93 (2013)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GQG

1in 2007

2007: 1
2007high 1 (2007) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GQG

2in 2025

2009: 12018: 12020: 12021: 52022: 32023: 62024: 22025: 2
2007high 6 (2023) · low 0 (2007)2025

MAUDE reports naming product code GQG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—10
20080—00
20091—01
20102—00
20110—00
20121—00
201339300
20140—00
20150—00
20160—00
20171—00
20180—01
20190—00
20200—01
20210—05
20220—03
20230—06
20241—02
20250—02
20261—0—

What is it indicated for?

The Directigen EZ RSV test is a rapid chromatographic immunoassay for the direct and qualitative detection of Respiratory Syncytial Virus (RSV) antigen in nasopharyngeal washes, nasopharyngeal aspirates, nasopharyngeal swabs and nasopharyngeal swab/washes from patients suspected of having a viral respiratory infection. This test is intended for in vitro diagnostic use to aid in the diagnosis of Respiratory Syncytial Virus (RSV) infections in neonatal and pediatric patients under the age of 20. It is recommended that negative test results be confirmed by cell culture.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K101514: BD Directigen EZ RSV.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K101514

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026